Literature DB >> 19940833

Mumps outbreak - New York, New Jersey, Quebec, 2009.

.   

Abstract

Mumps is a vaccine-preventable viral infection characterized by fever and inflammation of the salivary glands and whose complications include orchitis, deafness, and meningo-encephalitis. In August 2009, CDC was notified of the onset of an outbreak of mumps in a summer camp in Sullivan County, New York. The outbreak has spread and gradually increased in size and is now the largest U.S. mumps outbreak since 2006, when the United States experienced a resurgence of mumps with 6,584 reported cases. On August 18, public health departments in Sullivan County, New York state, and CDC began an investigation into the mumps outbreak, later joined by departments in New York City and other locales. As of October 30, a total of 179 confirmed or probable cases had been identified from multiple locations in New York and New Jersey, and an additional 15 cases had been reported from Canada. The outbreak primarily has affected members of a tradition-observant religious community; median age of the patients is 14 years, and 83% are male. Three persons have been hospitalized. Although little transmission has occurred outside the Jewish community, mumps can spread rapidly in congregate settings such as colleges and schools; therefore, public health officials and clinicians should heighten surveillance for mumps and ensure that children and adults are appropriately vaccinated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940833

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

2.  Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.

Authors:  James Zengel; Shannon I Phan; Adrian Pickar; Pei Xu; Biao He
Journal:  Vaccine       Date:  2017-06-13       Impact factor: 3.641

Review 3.  Measles, mumps, and rubella.

Authors:  Sarah J White; Kristi L Boldt; Sara J Holditch; Gregory A Poland; Robert M Jacobson
Journal:  Clin Obstet Gynecol       Date:  2012-06       Impact factor: 2.190

4.  A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents.

Authors:  Zary Nokhodian; Behrooz Ataei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Seyed Mohsen Zahraei; Roya Kelishadi
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

5.  Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate.

Authors:  Pei Xu; Zhixiang Huang; Xiudan Gao; Frank J Michel; Gwen Hirsch; Robert J Hogan; Kaori Sakamoto; Wenzhe Ho; Jianguo Wu; Biao He
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

6.  Mumps Virus Nucleoprotein and Hemagglutinin-Specific Antibody Response Following a Third Dose of Measles Mumps Rubella Vaccine.

Authors:  Donald R Latner; Amy Parker Fiebelkorn; Marcia McGrew; Nobia J Williams; Laura A Coleman; Huong Q McLean; Steven Rubin; Carole J Hickman
Journal:  Open Forum Infect Dis       Date:  2017-12-08       Impact factor: 3.835

Review 7.  Mass Gatherings and Respiratory Disease Outbreaks in the United States - Should We Be Worried? Results from a Systematic Literature Review and Analysis of the National Outbreak Reporting System.

Authors:  Jeanette J Rainey; Tiffani Phelps; Jianrong Shi
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

8.  Waning Immunity Is Associated with Periodic Large Outbreaks of Mumps: A Mathematical Modeling Study of Scottish Data.

Authors:  Dalila Hamami; Ross Cameron; Kevin G Pollock; Carron Shankland
Journal:  Front Physiol       Date:  2017-04-25       Impact factor: 4.566

9.  SARS-CoV-2 vs smallpox: mass vaccinations in the mirror.

Authors:  Raffaella Bianucci; Andreas G Nerlich; Emanuele Cigliuti; Simon T Donell; Antonio Perciaccante
Journal:  Intern Emerg Med       Date:  2021-04-13       Impact factor: 5.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.